The immediate effects of fitting and tuning solid ankle–foot orthoses in early stroke rehabilitation by Carse, Bruce et al.
Strathprints Institutional Repository
Carse, Bruce and Bowers, Roy and Meadows, Barry C. and Rowe, Philip 
(2015) The immediate effects of fitting and tuning solid ankle–foot 
orthoses in early stroke rehabilitation. Prosthetics and Orthotics 
International, 39 (6). pp. 454-462. ISSN 0309-3646 , 
http://dx.doi.org/10.1177/0309364614538090
This version is available at http://strathprints.strath.ac.uk/50999/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
1 
 
Title page 
Title: The immediate effects of fitting and tuning solid ankle-foot orthoses (AFOs) in early 
stroke rehabilitation 
Authors: Dr Bruce Carse, Dr Barry Meadows, Mr Roy Bowers and Professor Philip Rowe 
Dr Bruce Carse, Biomedical Engineering, University of Strathclyde, 106 Rottenrow, 
Glasgow, G4 0NW, UK.  Email: bruce.carse@strath.ac.uk, Telephone: +(44) 141 548 3028. 
Dr Barry Meadows, WestMARC, Southern General Hospital, 1345 Govan Road, Glasgow, 
G51 4TF, UK.  Email: barry.meadows@ggc.scot.nhs.uk, Telephone: +(44) 141 201 2642. 
Mr Roy Bowers, Biomedical Engineering, University of Strathclyde, Curran Building, 131 St 
James Road, Glasgow, G4 0LS, UK. Email: r.j.bowers@strath.ac.uk, Telephone: +(44) 141 
548 4699. 
Prof. Philip Rowe, Biomedical Engineering, University of Strathclyde, 106 Rottenrow, 
Glasgow, G4 0NW, UK.  Email: philip.rowe@strath.ac.uk , Telephone: +(44) 141 548 3032. 
  
2 
 
Abstract 
Background: The objective was to determine the immediate spatiotemporal and kinematic 
effect of custom-made solid AFOs in early stroke rehabilitation, compared to shod walking. 
Study design: A pre-post-test  self-controlled experimental study.  
Methods: Five male and three female participants were recruited to the study (n=8), with a 
mean age of 57 (16) years who were 3.5 (3) weeks post-stroke.  Each received a custom-
made solid AFO to a predefined set of design criteria and tuned using heel wedges to control 
the shank inclination angle during shod walking.  Repeated spatiotemporal and 3D gait 
measures were taken pre and immediately post-intervention. 
Results: With the solid AFO Wwalking velocity increased from 0.22 (0.2) to 0.36 (0.3) m/s 
(p<0.05), overall average step length increased from 0.28 (0.1) to 0.37 (0.1) m (p<0.05), 
cadence increased from 45 (19) to 56 (19) steps/min (p<0.05) and step length symmetry 
ratio increased from 0.65 (0.2) to 0.74 (0.2) (NS).  No clear changes were observed in the 
joint kinematics of the hip and knee. 
Conclusions: In our small group of in early stroke patients who were fitted with a solid AFO, 
immediate significant improvements occurred in walking speed, step length and cadence, 
when compared to walking with shoes only.Immediate spatiotemporal walking improvements 
occurred in this small group of early stroke patients who were fitted with solid AFOs.  These 
changes were not however reflected in joint kinematics profiles, which suggests that 
segment orientations may be of more clinical use during the AFO tuning process. 
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Introduction 
It is widely acknowledged that stroke is the most common cause of severe adult disability in 
the UK1, with gait dysfunction being the most commonly reported post-stroke disability.2 Gait 
dysfunction is highly significant for recovery from stroke, as those with low levels of 
ambulatory activity are more likely to suffer further health problems such as profound 
cardiovascular and metabolic deconditioning.3 
 
While quality of gait has been found to decline in the years following stroke4 one intervention 
that has proven successful in reducing that decline is the ankle-foot orthosis (AFO)5. At a 
national level, in Scotland a best practice statement (BPS) for the provision of AFO for stroke 
within the National Health Service (NHS) has been developed.6 The BPS was developed by 
practitioners in a working group from the fields of orthotics, physiotherapy, stroke nursing 
and bioengineering, staff of NHS Quality Improvement Scotland and a patient 
representative. A systematic literature review was undertaken to evidence recommendations 
made. The best practice statement contains information on the principles behind the use of 
AFOs and their role in stroke rehabilitation, a referral screening tool and a fitting/review tool.7 
 
At an international level, several studies have been conducted on the effects of AFO use in 
stoke rehabilitation. Franceschini et al. found increases in walking speed and cadence 
combined with decreases in stance time, double support time and reduced walking energy 
cost in patients who were a median of 39 months post-stroke (range 2-244 months).8 Gok et 
al. found that metallic and solid plastic AFOs provided an increase in walking speed, 
cadence and step length combined with a decrease in double support time and the authors 
concluded that the more rigid metallic AFO provided better outcomes than the plastic AFO 
tested.9 De Wit et al. found significant increases in walking speed, reduced time to complete 
timed up and go and stair ascent/descent tests. The study involved participants more than 
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six months post-stroke who had already been using a rigid plastic AFO for at least six 
months. The authors found however that none of the improvements could be considered 
clinically significant.10  Simons et al. found that AFOs provided improvements in the Berg 
Balance Scale, timed up and go, walking speed and Functional Ambulatory Category.11 The 
use of Chignon articulated AFOs was compared with off-the-shelf AFOs and it was 
concluded that the Chignon AFO provided a significantly higher level of immediate 
improvement in walking speed and selected kinematic parameters, and a larger reduction in 
spasticity measures over 90 days.12 
 
The studies mentioned above did not describe if an AFO footwear combination (AFO-FC) 
tuning process was used for the AFOs included in their methodology. Tuning the AFO-FC is 
the process of making fine adjustments to the design for biomechanical optimisation.13 
Typically these fine adjustments include the use of rocker soles and the iterative addition of 
heel wedges. While a recent review outlined the potential utility of AFO-FC tuning in children 
with cerebral palsy14 the only study that mentions post-stroke AFO-FC tuning is a case study 
where the kinetic and kinematic changes were detailed, and knee hyperextension was 
successfully eliminated.15 
 
Published algorithms for AFO tuning suggest that with >5° thigh inclination during the mid-to-
late stance phase (MTLS), and a shank-to-vertical angle (SVA) of 10-12°, combined with 
adequate control of the knee, it is possible to achieve a GRF alignment which successfully 
passes anterior to the knee joint centre, and posterior to the hip joint centre.16 Without 
correct segment orientation at this phase of the gait cycle, GRF alignment cannot be correct 
and therefore the correct signals cannot be sent from the hip proprioceptors to the central 
pattern generators, which are thought to use that signal as one of the inputs to for swing 
phase initiation.17,18 The AFO can be used to directly control the SVA at midstance, which if 
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correct should increase the likelihood of achieving correct segment orientation during the 
MTLS phase. 
 
Leung and Mosely reviewed AFO literature and while they found that AFO use may lead to 
immediate kinematic and spatiotemporal improvements in gait, however they also stated that 
issues surrounding impact on daily functionality, clinical implications for the wider population, 
long-term effects and compliance have not been resolved.19 Given the general consensus 
from the studies described above (i.e. that there are numerous positive effects from AFO use 
in stroke) it is surprising that the grade of recommendation in the recently published Scottish 
Intercollegiate Guidelines Network (SIGN) clinical guidelines remains low.20 While the 
reported positive effects of AFOs are plentiful, one problem is that none of these studies can 
be considered directly relevant to the stroke AFO service provided in many parts of the UK. 
An example of how these studies may not be applicable on a local level is that in NHS 
Greater Glasgow and Clyde, many in-patients are prescribed and receive an AFO as early 
as possible (1-8 weeks post-stroke) in agreement with recommendations on early 
mobilisation21,22 and the finding that AFOs provide more benefit earlier in the rehabilitation 
process.23  Of the studies cited above, Gok et al.9 studied the group with the earliest mean 
time since stroke at 9.5 weeks (range 1-38 weeks) whereas the others studied groups at a 
much later stage. 8,10-12 Furthermore, the AFO studies cited above also often refer to the use 
of varied types of AFO which, although available to the local NHS stroke AFO service 
orthotists and patients, are prescribed to a lesser extent than solid AFOs through the so their 
findings are not necessarily applicable. It was thought that a useful addition to the existing 
body of work would be description of the instantaneous effects of appropriately tuned AFOs 
at the point of provision with people at an early stage in their stroke rehabilitation. 
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The aim of this study was to investigate the immediate spatiotemporal and kinematic effects 
of fitting and tuning solid AFOs on walking with patients who had suffered a recent 
hemiplegia, compared to their walking with no AFO.  The AFOs provided were similar to 
those provided as standard within the local clinical service. 
 
Methods 
Participants 
Five males and three females (Table 1) were recruited as part of an ongoing randomised 
controlled trial investigating the effectiveness of using biomechanical data to fit and tune 
AFOs.24  Participants in this study had to be within 1-12 months after stroke, over 16 years of 
age, meet the criteria for AFO referral as outlined in the NHS BPS (able to walk with 
assistance but had difficulty flexing knee and extending hip during gait), assessed by a 
participating NHS orthotist and judged suitable for a custom solid AFO.  Participants had a 
mean age of 57 (16) years and were 3.5 (3) weeks post-stroke.  
AFO design and fabrication 
All participants and received a custom solid AFO (Figure 1) designed and fabricated by the 
participating NHS orthotists using the following design criteria: 
1. The AFO must not position the ankle in a more dorsiflexed position than can be achieved 
with the knee fully extended (i.e. the gastrocnemius length). This means the AFO may in 
some circumstances hold the ankle in a plantar flexed position. 
2. The AFO should give an initial shank-to-vertical angle (SVA) of 0 degrees when placed on 
a flat surface without a shoe. A permanent wedge should be attached to achieve this if the 
AFO holds the ankle in a plantar flexed position.  
3. 5mm homopolymer polypropelene should be used. 
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4. Carbon fibre reinforcements should be used, with their leading edge placed at the midline 
of each malleolus. 
5. There should be no noticeable deflection when the AFO is forced into plantarflexion or 
dorsiflexion. There should be no outward bulging at the malleoli when the AFO is forced into 
dorsiflexion. 
6. Trimlines should be approximately 10mm anterior to the midline of the malleoli. At the 
forefoot, the medial and lateral trimlines should be close to the metatarsal heads, to allow for 
control of supination/pronation and forefoot adduction/abduction. The sole plate should 
extend at least 5mm beyond the toes. 
7. Straps shoulGEHPDGHRI9HOFURRUZHEELQJEDFNHGZLWK9HOFUR. The top strap 
should be no more than 10-15mm from the top of the AFO. The lower strap should apply a 
force in a posterior and inferior direction, at roughly 45 degrees to the vertical, to the dorsum 
of the foot. 
3D gait analysis 
In order to implement a pre-post-test experimental design, 3D gait analysis measures were 
taken on two occasions; one before the AFO was fitted walking with shoes only (baseline 
session), and another 7 days later immediately after the AFO was fitted and tuned (tuning 
session). During the tuning session the AFO was fitted by one of two practicing NHS 
orthotists, and heel wedges were added such that a suitable SVA (thought to be 10-12°) at 
midstance16 was judged to have been achieved. Rocker soles were not used. 
 
3D gait analysis was conducted using an 8-camera Vicon 612 system (Oxford Metrics, UK) 
in conjunction with two AMTI BP400600 force platforms. Participants had a total of 34 
reflective markers (18 single markers and four rigid clusters, each comprising four markers) 
attached to key anatomical landmarks. Single markers were placed on the pelvis (left and 
8 
 
right, anterior and posterior superior iliac spine), the knees (medial and lateral epicondyles), 
the ankles (medial and lateral malleoli) and the feet (calcaneus, first and fifth metatarsal 
heads). Rigid clusters of four asymmetrical markers were attached to thigh and shank 
segments such that the eight single knee and ankle markers could be removed after a static 
calibration was captured and these were reconstructed using the rigid clusters during 
subsequent walking trials. 
 
All gait trials were conducted in a shod condition with feet markers attached to the outside of 
the shoe.  Patients walked in outdoor shoes of their choosing during the baseline session, 
and all were given a pair of basic training shoes for the AFO fitting and tuning session.  
7KHVHVKRHVKDGDIDLUO\ULJLGVROHDVPDOOKHHOWRWRHGLIIHUHQWLDOPPDQGWKUHH9HOFUR
straps which allowed for easy insertion/removal of the AFO and heel wedges.  
 
Post-capture processing was carried out on the data collected using code which derived the 
hip joint centres from the pelvic markers25 and calculated 3D hip, knee and ankle joint angles 
using the joint coordinate system described by Cole et al.26 
 
Outcome measures  
Spatiotemporal parameters of walking velocity, step length symmetry ratio (longest step 
divided by shortest step), overall average step length and cadence were calculated using the 
3D motion analysis data. Average walking velocity was calculated using the differential of the 
displacement of the midpoint of the left and right ASIS markers on the pelvis with respect to 
the global horizontal direction of travel.  
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Both the shank-to-vertical angle (SVA) and the thigh-to-vertical angle (TVA) of the affected 
limb were calculated from the 3D motion data using 3D global segment orientations.  An 
Euler angle sequence of 'tilt-obliquity-rotation' was used to describe the segment relative to 
the laboratory, whereby the tilt component represented the forward/backward inclination of 
the segment.  The convention used was forward inclination of the segment with respect to 
the participant's direction of travel was taken to be positive. A spatial definition of midstance 
was used and was taken as the point at which the ankle joint centres were level in the 
horizontal direction of travel. Thigh-to-vertical angle (TVAmax) of the affected limb was taken 
at its point of maximum inclination, which usually occurred during the mid-to-late stance 
phase (MTLS), which is described as the time between midstance and prior to toe-off. Knee 
flexion for the affected limb was taken at the same time point as TVAmax, with normal values 
at this point of the gait cycle being 10-18° flexion27. Additional baseline measures such as 
the modified Rivermead Mobility Index (mRMI)28 and the Euroqol EQ-5D-5L29 quality of life 
questionnaire were also taken. Walking velocity was considered as the primary outcome 
measure as walking velocity gains have been shown to contribute to a higher class of 
ambulation category and result in increased function and quality of life.30 
 
Ethical approval 
This study was granted ethical approval by the NHS xxxxxxxx Ethics Committee (Ref: 
xxxxxx) and the xxxxxxxxx (University) Research Ethics Committee. All participants were 
asked for their informed consent prior to inclusion in the study. 
 
Statistical Analysis 
A nonparametric Wilcoxon signed rank test was used to test for significant differences before 
and after AFO fitting and tuning.   
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Results 
The mean number of gait cycles captured for each participant was 10 at baseline and seven 
immediately post AFO tuning. There were a number of changes in the spatiotemporal 
parameters measured between baseline and immediately after the AFO had been fitted and 
tuned, as shown in Table 2. All but one participant (P7) showed an increase in their walking 
speed. The walking speed increase across all participants was statistically significant 
(p=0.021). Only one participant (P8) did not show an increase in their step length symmetry, 
although the increases across all other participants were not statistically significant 
(p=0.082). All participants had a longer step length with their paretic limb compared with 
their non-paretic limb, although two did not always consistently follow this pattern through all 
gait trials (P2 and P5). All but one participant (P7) showed an increase in overall average 
step length. The overall step length increase across all participants was statistically 
significant (p=0.021), as was the increase in cadence (p=0.042). 
 
For the majority of participants affected limb segment orientation kinematics moved closer to 
pre-defined target values (i.e. SVA 10-12° inclination, TVAmax >5° inclination) as shown in 
Table 3 although none of these differences were statistically significant. SVA changes 
towards the target values were apparent in most participants, except for P3 who changed 
from 11.3 (6.7) ° to 6.3 (6.2) °, and P6 who moved marginally outside the target range from 
10.4 (1.9)° to 12.4 (1.1)°. Small TVAmax changes towards target values were observed in four 
participants; P1, P2, P5 and P7 with a large change observed in P3 (-7.7 (7.2)° to 10.3 
(3.6)°). A reduction in the TVAmax for P6 was observed from -4 (2.4)° to -8.4 (2.5)°, as was 
the case for P4 (4.9 (4.6)° to -3.8 (5.8)°). 
 
Knee flexion angles were changed for P5, with knee hyperextension eliminated (-2.3 (2.1)° 
to 10.4 (0.3)°). Knee hyperextension was marginally reduced in P2 (-3.8 (4.4)° to -3.1 (0.7)°). 
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In addition to reducing hyperextension in some participants, in others the tuned AFO 
reduced excessive knee flexion in P1 (27.9 (4.9)° to 20 (5.4)°) and P3 (27.6 (6.4)° to 10.9 
(2.7)°). The tuned AFO changed knee flexion angles such that they deviated further from 
normal ranges (10-18° flexion) in two participants, with P4 experiencing a knee flexion 
increase from 5.7 (5)° to 19.7 (5.1)° and P6 an increase from 20.7 (3.2)° to 24.9 (3.1)°. 
 
Sagittal knee and hip joint angles throughout the gait cycle at baseline and post-tuning and 
are shown in Figure 2 for all participants. All participants (with the exception of P2 and P4) 
exhibited excessive amounts of knee flexion at initial contact during baseline sessions (see 
knee profiles in Figure 2: P1, P3, P5, P6, P7 and P8). Few participants achieved any hip 
extension at baseline (see hip profiles in Figure 2), and the AFO appeared to have an 
immediate positive effect on hip extension for P3 and P8 with no positive effect on the other 
six participants. 
 
Discussion 
The majority of participants experienced improvements for all spatiotemporal parameters 
indicated in Table 2, with only P7 and P8 showing any deterioration although neither 
deteriorated with regards all parameters. While the improvements in walking speed were 
statistically significant, only one participant (P5) showed an immediate clinically significant 
increase of >0.2m/s.31  
 
The goal with the AFO intervention is to get the patient to walk as close to normal as 
possible.30,31 In order to achieve that it was proposed that for the paretic limb, the SVA at 
midstance should be 10-12° inclined16, and at mid-to-late stance (MTLS) the thigh should be 
inclined (>5°) with the knee slightly flexed at approximately 10-18°.27 By using the AFO to 
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directly control the SVA at midstance, the likelihood of achieving correct segment orientation 
during the MTLS phase should have be increased, thus allowing a correct GRF alignment. 
Intervening with segment orientations in this way is likely to influence motor control by 
attempting to ensure that the correct signals are sent to the central pattern generators. 
 
Theoretically if these three kinematic parameters were correct, the patient should have seen 
a significant improvement in their gait pattern, as indicated by the spatiotemporal 
parameters. While there was a general trend for the group towards improvement regarding 
these three parameters (such that they were brought closer to normal target values), the 
only participant who experienced clear immediate improvements in all three parameters was 
P5 (Table 3). This participant also had the most significant improvement in walking velocity 
(0.6m/s), improved their symmetry from 0.73 to 0.95, cadence from 42.4 to 54.7 steps/min 
and had the largest increase in their overall step length from 0.31m to 0.53m (Table 2). P2 
also experienced improvements in all three kinematic parameters (only marginal 
improvement in knee flexion from -3.8 (4.4)° to -3.1 (0.7)°) and improved their walking 
velocity by 0.14m/s, symmetry from 0.88 to 0.9, step length from 0.48 to 0.63m although 
decreased their cadence from 81.2 to 78.5 steps/min (Table 2).  Another participant whose 
data supported this theory was P6, as they appeared to experience the least improvement in 
the three kinematic parameters (Table 3) and exhibited some of the smallest improvements 
in their spatiotemporal parameters (Table 2).  
 
One participant who experienced mixed improvements in the three kinematic parameters 
was P3 as they achieved an improvement in TVAmax and knee flexion angle at TVAmax, 
although his SVA moved further away from the target values.  Despite this, P3 improved with 
regard to their spatiotemporal parameters. P3 did have a highly variable SVA values 
(standard deviations of 6.7° and 6.2°) whereas other participants had considerably lower 
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SVA standard deviations (0.3° to 2.4°).  This suggests that P3 walked in an inconsistent 
manner both before and immediately after their AFO provision.  While their AFO may have 
been tuned appropriately during standing, some unexplained lack of motor control or muscle 
imbalance meant the AFO could not adequately control the shank segment.  This suggests 
that it is important to assess the SVA in both standing and at midstance during gait.  It is 
unknown whether or not P3 would have achieved better immediate spatiotemporal outcomes 
were the AFO able to consistently keep his SVA at the target 10-12° at midstance.  P3 also 
had the lowest mRMI score, the highest Euroqol score and was the oldest participant which 
suggests an acceptance of his poor mobility levels, and possibly had lower expectations 
from his rehabilitation programme than the younger participants.  Despite this, P3 did benefit 
from AFO fitting and tuning, which suggests that tuned AFOs can help patients who have 
very limited mobility and potentially low levels of motivation. 
 
The individual cases described above only suggest a link between correct AFO fitting and 
tuning with respect to the three kinematic parameters and improvements in their 
spatiotemporal gait parameters.  This study would have needed greater numbers of 
participants to allow a meaningful investigation of any correlations between spatiotemporal 
and kinematic parameters. 
  
Ideally every participant would have received an AFO which provided improvements for the 
three identified kinematic parameters, as was the case with P5. Table 3 shows that this was 
not achieved in this study. It could be the case that a tuned AFO cannot achieve all of these 
LPSURYHPHQWVZLWKHYHU\VWURNHSDWLHQWDWRQFHJLYHQHDFKSDUWLFLSDQW¶VXQLTXHFRPELQDWLRQ
of gait abnormalities. Often one kinematic parameter was improved but to the detriment of 
another, for example P4 experienced an improvement in SVA combined with a deterioration 
in TVAmax. A particular hindrance to achieving these improvements in all participants was 
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that the AFO tuning process was not as exhaustive as it could have been. With participants 
ranging from 1-8 weeks post-stroke, they often fatigued very quickly, so only a small number 
of different wedge heights could be tested therefore the optimal solution was perhaps not 
obtainable in the time available.  
 
The time point at which the maximum response to a solid AFO occurs is currently not known.  
It is likely the case that improvements in all kinematic parameters (except for SVA at 
midstance) do not occur immediately, therefore it would be useful to take further 3D gait 
analysis measurements with these participants at three and six months, which could prove to 
be particularly important given the varying rates of improvement seen with different AFOs as 
reported by de Seze et al.12 The target values for SVA, TVAmax and knee flexion at TVAmax 
used in this study (see Table 3) were taken from different sources and were collected using 
different techniques, so future work in this area should also be done to clearly define the 
mean and standard deviation values for these three parameters in normal healthy 
participants.  Such data could then be used for creating robust target values for AFO fitting 
and tuning sessions.   
 
While it remains unclear if segment orientation kinematic parameters are good predictors of 
the success of an AFO, they would appear to be more practical than the hip and knee joint 
kinematics profiles (which are regularly provided in gait analysis reports) shown in Figure 2. 
Given that much AFO fitting and tuning occurs without the use of 3D motion analysis 
systems it may be pragmatic to suggest that clinicians to focus on segment orientations 
when conducting observational gait analysis.  The use of a larger sample size would allow 
any correlations that exist between these three kinematic parameters and spatiotemporal 
gait improvements to be investigated fully. In doing so the nature of the improvements 
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offered by solid AFOs and appropriate fitting and tuning techniques could be better 
understood. 
 
Overall this study broadly agrees with the previous studies 5,8-12,19 in that it shows a general 
improvement in spatiotemporal walking parameters in stroke patients with AFOs.  It 
describes in detail how a local protocol for custom-made, solid AFOs that have been tuned 
can be used to provide to early stroke patients with statistically significant walking 
improvements. 
 
Conclusions 
This study has shown that custom-made solid AFOs are likely to cause an immediate 
increase in gait velocity, overall step length and cadence in persons who are at an early 
stage stroke of stroke rehabilitation, although levels of improvement were variable. While the 
AFO fitting and tuning process does improve spatiotemporal parameters of walking speed, 
overall step length and cadence, it did not have a noticeably positive effect on hip and knee 
kinematic profiles. The three kinematic parameters discussed (SVA, TVAmax and knee flexion 
at TVAmax) were moved closer to normal ranges through the use of AFOs and although these 
changes were not significant, they may ultimately prove to be useful in assisting clinicians to 
achieve optimal AFO tuning during routine clinical sessions. 
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Figure 1 Custom made rigid AFO as specified by study design criteria 
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Figure 2: Hip and knee flexion extension profiles, showing the affected limb only. 
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Solid line shows mean baseline measures, dotted line shows post-AFO fitting and tuning measures.  
Light grey shading shows normal reference data (±1SD) from healthy older adults.  
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Table 1 Participant characteristics at baseline 
Participant Gender Age 
Time after 
stroke 
(weeks) 
Affected side 
Type of 
stroke* 
mRMI score 
Euroqol VAS 
Score 
P1 F 50 8 R TACS 27 42 
P 2 M 53 1 L LACS 36 40 
P 3 M 87 5 R LACS 18 75 
P4 M 53 3 R PACS 39 50 
P5 M 40 2 R TACS 32 70 
P6 M 57 3 L LACS 23 30 
P7 F 74 2 L LACS 34 70 
P8 F 42 4 L TACS 24 0 
Modified Rivermead Mobility Index (mRMI), range 0-40.Euroqolself-reported overall health related quality 
of life Visual Analogue Score (VAS), range 0-100. *Type of stroke using the Bamford classification system. 
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Table 2 Changes in spatiotemporal parameters pre and immediately post-AFO fitting and tuning 
  Velocity (m/s)  Step-length symmetry ratio  Overall average step length (m)  Cadence (steps/min) 
Participant 
 
Baseline Tuning Diff  Baseline Tuning Change Paretic step 
longer? 
 Baseline Tuning Diff  Baseline Tuning Diff 
P1  0.08 0.1 0.02  0.68 0.71 0.02 Yes  0.17 0.27 0.1  26.4 28.7 2.3 
P2  0.68 0.82 0.14  0.88 0.9 0.03 YesÁ  0.48 0.63 0.15  81.2 78.5 -2.7 
P3  0.08 0.14 0.06  0.4 0.91 0.51 Yes  0.22 0.32 0.1  23.9 31.1 7.2 
P4  0.15 0.23 0.09  0.54 0.59 0.05 Yes  0.27 0.3 0.03  53.7 54.1 0.4 
P5  0.19 0.79 0.6  0.73 0.95 0.22 YesÁ  0.31 0.53 0.22  40.1 80 39.9 
P6  0.17 0.26 0.09  0.4 0.4 0 Yes  0.24 0.3 0.06  42.4 54.7 12.3 
P7  0.29 0.28 -0.01  0.8 0.89 0.09 Yes  0.35 0.34 -0.01  59.8 65.3 5.5 
P8  0.11 0.23 0.12  0.79 0.54 -0.24 Yes  0.2 0.27 0.07  34.2 53.6 19.5 
Normal  1.18 (0.16)*  0.97 (0.02)**  0.59 (0.07)*  120 (10)* 
Statistically significant group difference (p<0.05) with Wilcoxon Signed Rank Test 
Á3DUHWLFVWHSOHQJWKORQJHURQPDMRULW\RIsteps, but not consistently 
* Normal reference data taken from Oberg et al.32 
** Normal reference data taken from Patterson et al.33 
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Table 3 Changes in segment kinematic parameters pre and immediately post-AFO fitting 
and tuning, shown as Mean (SD) 
Participant  SVA (°)  TVAmax (°)  Knee Flexion (°) 
  Baseline Tuning  Baseline Tuning  Baseline Tuning 
P1  16.7 (3) 9.6 (1.6)  -4.2 (3) -0.9 (3.2)  27.9 (4.9) 20 (5.4) 
P2  -1.6 (1.9) 8.2 (0.3)  17.5 (3) 20.9 (0.9)  -3.8 (4.4) -3.1 (0.7) 
P3  11.3 (6.7) 6.3 (6.2)  -7.7 (7.2) 10.3 (3.6)  27.6 (6.4) 10.9 (2.7) 
P4  4.6 (1.6) 9.4 (2.4)  4.9 (4.6) -3.8 (5.8)  5.7 (5) 19.7 (5.1) 
P5  -0.7 (2) 14.2 (1)  12.7 (2.4) 14.3 (2.1)  -2.3 (2.1) 10.4 (0.3) 
P6  10.4 (1.9) 12.4 (1.1)  -4 (2.4) -8.4 (2.5)  20.7 (3.2) 24.9 (3.1) 
P7  8.4 (1.5) 16.4 (1.1)  6.7 (3.1) 7.4 (3.3)  13.6 (4.1) 12.6 (4.2) 
P8  3.4 (0.9) 15.1 (2.1)  10.6 (1.7) 10.3 (2.7)  4.4 (1.5) 9.3 (2.2) 
Combined mean  6.6 (6.3) 11.5 (3.6)  4.6 (9.1) 6.3 (9.9)  11.7 (12.7) 13.1 (8.6) 
Target values  10-12°  >5°  10-18° 
No statistically significant group difference (p>0.05) with Wilcoxon Signed Rank Test 
 
 
